Who has invested in ARGOBIO?

Bpifrance, Kurma Partners, Angelini Pharma, Evotec, Institut Pasteur are named among the investors backing ARGOBIO.

ARGOBIO Funding: $60M Raised, Series A (2021)

ARGOBIO funding overview

ARGOBIO is based in Paris, France. ARGOBIO has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for ARGOBIO runs through 2021; nothing later has been disclosed. Investors on record include Bpifrance, Kurma Partners, Angelini Pharma, Evotec, Institut Pasteur. 5 distinct backers are named across the disclosed rounds.

ARGOBIO at a glance

Total raised: $60M
Latest round: Series A
Latest round date: March 2021
Headquarters: Paris, France
Notable investors: Bpifrance, Kurma Partners, Angelini Pharma, Evotec, Institut Pasteur

Frequently asked about ARGOBIO funding

How much has ARGOBIO raised?: ARGOBIO has raised $60M in total disclosed funding across the rounds on record.
Who has invested in ARGOBIO?: Bpifrance, Kurma Partners, Angelini Pharma, Evotec, Institut Pasteur are named among the investors backing ARGOBIO.
What was the latest ARGOBIO funding round?: The most recent disclosed round is a Series A, announced in March 2021.
Where is ARGOBIO based?: ARGOBIO is based in Paris, France.
When did ARGOBIO last raise?: The last disclosed ARGOBIO round closed in March 2021 at Series A.

Totals shown for ARGOBIO aggregate every disclosed round on file. To see how that compares, browse the companies in Paris and the investors behind them below.

ARGOBIO Funding: $60M Raised, Series A (2021)

ARGOBIO funding overview

ARGOBIO at a glance

Frequently asked about ARGOBIO funding

Companies related to ARGOBIO (35)

Browse related funding lists (6)